Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	720.74	712.81	593.24	498.99	437.77	349.85
Other Revenue	1.94	19.15	51.16	-	-	-
Revenue	722.68	731.97	644.4	498.99	437.77	349.85
Revenue Growth (YoY)	1.37%	13.59%	29.14%	13.98%	25.13%	8.53%
Cost of Revenue	362.35	358.11	290.57	250.13	238.03	206.51
Gross Profit	360.33	373.86	353.82	248.86	199.74	143.34
Selling, General & Admin	99.27	94.52	80.39	66.59	67.12	62.86
Research & Development	79.4	73.91	73.74	74.77	60.93	67.23
Operating Expenses	178.66	168.44	154.13	141.36	128.05	130.09
Operating Income	181.67	205.42	199.69	107.5	71.69	13.25
Interest Expense	-31.89	-35.34	-33.06	-1.85	-0.89	-0.37
Interest & Investment Income	8.73	10.61	5.46	1.32	0.6	0.64
Earnings From Equity Investments	-	-0.57	-1.98	-1.18	-0.21	-
Other Non Operating Income (Expenses)	3.33	9.08	1.97	9.07	13.54	6.22
EBT Excluding Unusual Items	161.84	189.19	172.08	114.86	84.73	19.74
Asset Writedown	-	-	-2.7	-	-	-
Legal Settlements	-	-	-	-	1	-12.8
Other Unusual Items	-	-	-	-	-1.8	-2.3
Pretax Income	161.84	189.19	169.38	114.86	83.93	4.64
Income Tax Expense	27.13	29.67	31.83	23.48	20.63	3.54
Earnings From Continuing Operations	134.71	159.52	137.55	91.39	63.3	1.1
Minority Interest in Earnings	-	-	-	-	-1.19	0.31
Net Income	134.71	159.52	137.55	91.39	62.12	1.4
Net Income to Common	134.71	159.52	137.55	91.39	62.12	1.4
Net Income Growth	-19.10%	15.98%	50.51%	47.12%	4327.37%	-97.13%
Shares Outstanding (Basic)	48	48	48	49	48	47
Shares Outstanding (Diluted)	50	52	53	52	50	49
Shares Change (YoY)	-5.10%	-1.78%	1.09%	5.31%	1.34%	-1.57%
EPS (Basic)	2.82	3.29	2.85	1.88	1.30	0.03
EPS (Diluted)	2.68	3.06	2.60	1.74	1.25	0.03
EPS Growth	-14.81%	17.69%	49.43%	39.20%	4090.97%	-96.96%
Free Cash Flow	112.19	172.35	145.34	65.15	70.54	23.41
Free Cash Flow Per Share	2.23	3.31	2.74	1.24	1.42	0.48
Gross Margin	49.86%	51.08%	54.91%	49.87%	45.63%	40.97%
Operating Margin	25.14%	28.06%	30.99%	21.54%	16.38%	3.79%
Profit Margin	18.64%	21.79%	21.34%	18.31%	14.19%	0.40%
Free Cash Flow Margin	15.52%	23.54%	22.55%	13.06%	16.11%	6.69%
EBITDA	236.73	258.39	237.72	132.27	94.95	34.78
EBITDA Margin	32.76%	35.30%	36.89%	26.51%	21.69%	9.94%
D&A For EBITDA	55.06	52.97	38.04	24.77	23.27	21.53
EBIT	181.67	205.42	199.69	107.5	71.69	13.25
EBIT Margin	25.14%	28.06%	30.99%	21.54%	16.38%	3.79%
Effective Tax Rate	16.77%	15.68%	18.79%	20.44%	24.58%	76.34%
Revenue as Reported	722.68	731.97	644.4	498.99	437.77	-
Advertising Expenses	-	10.5	10.4	8.7	8.1	5.8

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q